peptide elongation factor 2 has been researched along with myriaporone 3 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Muthukumar, Y; Raja, A; Roy, M; Sasse, F; Taylor, RE | 1 |
1 other study(ies) available for peptide elongation factor 2 and myriaporone 3
| Article | Year |
|---|---|
The marine polyketide myriaporone 3/4 stalls translation by targeting the elongation phase.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Bryozoa; Cell Line; Cell Line, Tumor; Cell Proliferation; Elongation Factor 2 Kinase; Epoxy Compounds; Humans; Neoplasms; Peptide Elongation Factor 2; Phosphorylation; Protein Biosynthesis; Pyrans | 2013 |